Back

Chapter review

Chapter 12

Personality Disorders

138 topics · 30 traps · 31 safety · 8 car scripts

  1. Scan must-know (one line per topic).
  2. Read every board trap and safety card.
  3. Quiz this chapter, then watch with study-along.
  4. Play car scripts in Speechify or read them here.

Chapter diagrams

Must know

  • Diagnostic Criteria Area 1: Cognition and AffectGeneral diagnostic criteria require an enduring, pervasive, and inflexible pattern of inner experience and behavior deviating from cultural norms, with onset in adolescence or early adulthood at the latest, affecting 10% to 20% of the general population and up to 50% of psychiatric inpatients.
    • General diagnostic criteria require an enduring, pervasive, and inflexible pattern of inner experience and behavior deviating from cultural norms, with onset in adolescence or early adulthood at the latest, affecting 10% to 20% of the general population and up to 50% of psychiatric inpatients.
    • Diagnosis requires demonstrable impairment in at least 2 of 4 core domains: cognition, affectivity, interpersonal functioning, or impulse control.
    • Area 1 Cognition represents ineffective cognitive capacity characterized by immature and distorted interpretations of self, others, and environmental events.
    • Area 2 Affectivity represents affect abnormality characterized by intense emotional lability, extreme affective range, and inappropriate emotional responses.
    • Genetics play a strong role, with monozygotic twin concordance several times higher than dizygotic twins, and first-degree biological relatives having a 5 times higher risk for borderline personality disorder.
    • Primitive defense mechanisms including fantasy, splitting, and projection dominate clinical presentations and impair coping.
  • Etiology, Defense Mechanisms, and Clinical ImpactPsychotherapy is the primary treatment modality for personality disorders, with dialectical behavior therapy (DBT) serving as gold-standard care for borderline personality disorder. Psychopharmacology is strictly adjunctive. SSRIs like sertraline treat co-occurring depressive and anxiety symptoms, while low-dose antipsychotics like risperidone target cognitive-perceptual distortions or acute behavioral dysregulation.
    • Psychotherapy is the primary treatment modality for personality disorders, with dialectical behavior therapy (DBT) serving as gold-standard care for borderline personality disorder. Psychopharmacology is strictly adjunctive. SSRIs like sertraline treat co-occurring depressive and anxiety symptoms, while low-dose antipsychotics like risperidone target cognitive-perceptual distortions or acute behavioral dysregulation.
    • Assess for severe self-harm, suicidal ideation, and rapid emotional decompensation during relationship disruptions. Personality disorders significantly increase the risk of high-risk impulsive behaviors and accidental or intentional self-injury.
    • Do not prescribe medication as a cure for the core personality disorder itself. Psychotropics only target comorbid symptom clusters like mood dysregulation or psychosis. Additionally, do not mistake primitive defenses like splitting for primary psychotic disorders. When terminating care due to boundaries, provide a formal certified letter, referral options, and a 30 to 60 day supply of essential medications to prevent abandonment claims.

    Board trap. Do not prescribe medication as a cure for the core personality disorder itself. Psychotropics only target comorbid symptom clusters like mood dysregulation or psychosis. Additionally, do not mistake primitive defenses like splitting for primary psychotic disorders. When terminating care due to boundaries, provide a formal certified letter, referral options, and a 30 to 60 day supply of essential medications to prevent abandonment claims.

    Safety. Assess for severe self-harm, suicidal ideation, and rapid emotional decompensation during relationship disruptions. Personality disorders significantly increase the risk of high-risk impulsive behaviors and accidental or intentional self-injury.

  • Diagnostic Criteria Area 2: Interpersonal and Impulse ControlGeneral Diagnostic Criteria: A personality disorder is an enduring, inflexible pattern of inner experience and behavior that deviates markedly from cultural expectations, begins in adolescence or early adulthood, occurs across diverse settings, and causes significant distress or functional impairment.
    • General Diagnostic Criteria: A personality disorder is an enduring, inflexible pattern of inner experience and behavior that deviates markedly from cultural expectations, begins in adolescence or early adulthood, occurs across diverse settings, and causes significant distress or functional impairment.
    • The Two-Area Rule: Diagnosis requires demonstrated impairment in at least 2 of 4 core domains: cognitive capacity, affectivity, interpersonal functioning, and impulse control.
    • Epidemiology and Genetics: Personality disorders affect 10% to 20% of the general population and up to 50% of psychiatric clinical populations. Borderline personality disorder is 5 times more common among first-degree biological relatives.
    • Area 2 Core Deficits: Interpersonal functioning deficits manifest as persistent relationship dysfunction, detachment, or intense dependency, while impulse control deficits lead to self-destructive actions, angry outbursts, or reckless behaviors.
    • Primitive Defense Mechanisms: Patients rely on immature defense mechanisms, including splitting and projection, stemming from an inability to achieve object constancy.
    • First-Line Pharmacotherapy: Medications do not cure personality disorders. Use an SSRI such as sertraline for comorbid depression or anxiety, and low-dose antipsychotics like risperidone as adjunctive treatment for severe agitation, impulsivity, or brief psychotic episodes.
  • Clinical Mastery: Interpersonal Functioning and Impulse ControlPsychotherapy is the primary modality for managing personality pathology. For borderline personality disorder, DBT is the first-line evidence-based modality. When initiating treatment, setting clear limits and defining clinical roles is the essential first step in establishing the therapeutic relationship.
    • 1. Ineffective cognitive capacity, involving distorted ways of perceiving and interpreting self, others, and events.
    • 2. Affect abnormality, characterized by intense lability, mood dysregulation, or inappropriate emotional responses.
    • 3. Interpersonal functioning problems, marked by persistent conflict, social detachment, or excessive dependency.
    • 4. Impulse control difficulties, resulting in sudden behavioral outbursts, poor frustration tolerance, or self-destructive actions.

    Board trap. Prescribing psychotropic medications as a primary fix for personality disorders is a common board distractor. Medications are strictly adjunctive. When a patient with a personality disorder develops major depressive disorder, initiate standard first-line treatment with an SSRI such as sertraline, rather than second-line agents or mood stabilizers.

    Safety. Impulsivity and interpersonal distress frequently lead to high-risk behaviors, suicide threats, or self-harm. Clinicians must monitor for splitting, where patients view people or staff as all good or all bad. Splitting arises from a failure to achieve object constancy, making it difficult for the patient to maintain emotional stability when confronted with stress or separation.

  • Paranoid: Pervasive DistrustParanoid personality disorder is defined by a pervasive distrust and suspiciousness of others, where motives are interpreted as malevolent.
    • Paranoid personality disorder is defined by a pervasive distrust and suspiciousness of others, where motives are interpreted as malevolent.
    • General population prevalence for personality disorders ranges from 10% to 20%, rising up to 50% in psychiatric populations.
    • Diagnostic criteria require an enduring, inflexible pattern beginning in adolescence or early adulthood that manifests in at least 2 of 4 domains: cognitive capacity, affect, interpersonal functioning, or impulse control.
    • Etiology is multifactorial, showing higher concordance in monozygotic twins and dysregulation in dopamine and serotonin systems.
    • Individuals with paranoid personality disorder rely on primitive defense mechanisms, particularly projection, attributing their own unacceptable feelings onto others.
    • First-line psychotherapy requires a straightforward, warm, and honest approach, maintaining clear boundaries without validating or arguing against paranoid beliefs.
  • General Personality Disorder FrameworkPersonality disorders represent enduring, inflexible patterns of inner experience and behavior that deviate markedly from cultural expectations.
    • Personality disorders represent enduring, inflexible patterns of inner experience and behavior that deviate markedly from cultural expectations.
    • Symptoms cause significant impairment across social, occupational, and interpersonal spheres across diverse settings.
    • To meet general diagnostic criteria, a patient must exhibit dysfunction in at least 2 of the following 4 core areas:
    • 1. Ineffective cognitive capacity, involving immature or distorted perception of self, others, and events.
    • 2. Affect abnormality, characterized by intense, labile, or inappropriate emotional range.
    • 3. Interpersonal functioning deficits.
  • Cluster A Features and EpidemiologyCluster A is classified as the odd, eccentric, and aloof group, colloquially known as the "mad" cluster.
    • Cluster A is classified as the odd, eccentric, and aloof group, colloquially known as the "mad" cluster.
    • It comprises 3 specific diagnoses: paranoid personality disorder, schizoid personality disorder, and schizotypal personality disorder.
    • Genetic factors show increased rates of Cluster A traits among biological relatives of patients with schizophrenia.
    • Primitive defense mechanisms predominate in Cluster A, with projection being the hallmark defense in paranoid personality disorder.
  • Paranoid Personality Disorder ProfileCore feature: A pervasive, persistent pattern of distrust and suspiciousness toward others.
    • Core feature: A pervasive, persistent pattern of distrust and suspiciousness toward others.
    • Expectations of harm: Individuals assume others will exploit, harm, or deceive them, interpreting benign actions as hostile.
    • Interpretation of motives: Neutral comments and events are misinterpreted as malevolent or hidden insults.
    • Interpersonal impact: Hypervigilance, emotional coldness, and difficulty forming close relationships due to constant fear of betrayal.
  • Psychotherapeutic StrategyEstablish a therapeutic alliance built on a straightforward, warm, and honest style.
    • Establish a therapeutic alliance built on a straightforward, warm, and honest style.
    • Therapeutic challenge: Forming a close alliance is inherently difficult because the patient's primary pathology involves suspicion and wariness.
    • Handling odd thoughts: Maintain a nonjudgmental, neutral stance. Do not directly challenge or debate suspicious ideas; acknowledge feelings and gently redirect the patient to neutral, functional topics.
  • PsychopharmacotherapyTarget symptoms: Medications do not cure the underlying personality structure but manage specific comorbid symptoms.
    • Target symptoms: Medications do not cure the underlying personality structure but manage specific comorbid symptoms.
    • Mood and anxiety: Use standard SSRIs (such as sertraline) for co-occurring depression or generalized anxiety.
    • Psychotic-like symptoms: Low-dose antipsychotics (such as risperidone) are indicated for brief periods of severe agitation, extreme paranoia, or quasi-delusional thinking.
  • SignpostsPsychotherapy focused on trust building using a straightforward, honest, and nonjudgmental approach.
    • Psychotherapy focused on trust building using a straightforward, honest, and nonjudgmental approach.
    • Monitor for severe agitation or paranoid escalation. Assess for comorbid substance use or mood disorders, as primitive defense mechanisms like projection can lead to acute distress.
    • Confusing paranoid personality disorder with schizophrenia or delusional disorder. Paranoid personality disorder lacks fixed, persistent psychotic delusions or prominent auditory hallucinations. Do not prescribe high-dose chronic antipsychotics for non-psychotic paranoid traits.

    Board trap. Confusing paranoid personality disorder with schizophrenia or delusional disorder. Paranoid personality disorder lacks fixed, persistent psychotic delusions or prominent auditory hallucinations. Do not prescribe high-dose chronic antipsychotics for non-psychotic paranoid traits.

    Safety. Monitor for severe agitation or paranoid escalation. Assess for comorbid substance use or mood disorders, as primitive defense mechanisms like projection can lead to acute distress.

  • Chapter Bottom LineGeneral population prevalence: Personality disorders occur in 10% to 20% of the general population and in up to 50% of psychiatric patient populations.
    • General population prevalence: Personality disorders occur in 10% to 20% of the general population and in up to 50% of psychiatric patient populations.
    • Cluster A classification: Categorized as the odd, eccentric, and aloof group, encompassing schizoid personality disorder, paranoid personality disorder, and schizotypal personality disorder.
    • Schizoid core criteria: Defined by a pervasive pattern of detachment from social relationships and a restricted range of emotional expression in interpersonal settings starting by early adulthood across multiple contexts.
    • Etiology and neurotransmitters: Multifactorial etiology involving genetic predisposition and biological dysregulation of the dopamine and serotonin neurotransmitter systems.
    • Diagnostic criteria threshold: Requires at least two functional domain impairments across cognitive capacity, affectivity, interpersonal functioning, or impulse control.
    • First-line psychopharmacology: Pharmacotherapy does not cure primary personality traits; SSRIs are indicated for comorbid depression or anxiety, while small doses of antipsychotics may be used for severe agitation or quasi-psychotic symptoms.
  • Schizoid Personality DisorderWhat it is: A Cluster A disorder characterized by profound voluntary social withdrawal, indifference to social praise or criticism, preference for solitary activities, and blunted affect.
    • What it is: A Cluster A disorder characterized by profound voluntary social withdrawal, indifference to social praise or criticism, preference for solitary activities, and blunted affect.
    • Why boards care: Test writers frequently test the ability to differentiate schizoid personality disorder from avoidant personality disorder and schizotypal personality disorder.
    • Pervasive social detachment, lack of desire for close relationships including family, choosing solitary hobbies, lack of close friends, emotional coldness, and restricted affective range.
    • Typical board clue: An adult or adolescent who works night shifts or solitary jobs, has zero close friends, expresses no interest in dating, and appears emotionally unbothered by isolation.
    • First-line approach: A straightforward, warm, and honest therapeutic stance with low-intensity individual therapy.
    • First-line medication: No primary medication cures the personality structure; treat co-occurring depression or anxiety with SSRIs, and use small doses of antipsychotics only for severe agitation or perceptual disturbances.

    Board trap. Mistaking schizoid personality disorder for avoidant personality disorder; schizoid individuals prefer isolation and do not want social connection, whereas avoidant individuals strongly desire relationships but isolate due to intense fear of rejection.

    Safety. Extreme social detachment can mask severe medical illness or profound depression because the patient rarely seeks help spontaneously.

  • Schizoid Personality Disorder vs. Avoidant Personality DisorderThink: Schizoid is voluntary social detachment; avoidant is involuntary social isolation driven by social fear.
    • Think: Schizoid is voluntary social detachment; avoidant is involuntary social isolation driven by social fear.
    • Priority: Differentiate motivation for isolation to avoid inappropriate social exposures in therapy.
    • Boards are testing: Schizoid patients lack desire for relationships, whereas avoidant patients want connection but fear rejection.
    • Mini example: A computer programmer who lives alone, plays single-player video games, and explicitly states they do not need friends is exhibiting schizoid personality disorder.
  • Schizoid Personality Disorder vs. Schizotypal Personality DisorderThink: Schizoid is pure social detachment without odd beliefs; schizotypal adds cognitive distortions, magical thinking, and eccentricity.
    • Think: Schizoid is pure social detachment without odd beliefs; schizotypal adds cognitive distortions, magical thinking, and eccentricity.
    • Priority: Monitor schizotypal patients for potential conversion or overlap with psychotic disorders.
    • Boards are testing: Schizotypal individuals display magical thinking and ideas of reference, whereas schizoid individuals simply display emotional blunting and solitude.
    • Mini example: A patient who wears unusual clothing, believes in telepathy, and feels uncomfortable around people has schizotypal personality disorder.
  • Key ClueA. Avoidant personality disorder: Patients with avoidant personality disorder strongly desire social relationships but isolate due to severe fears of rejection, criticism, or inadequacy.
    • A. Avoidant personality disorder: Patients with avoidant personality disorder strongly desire social relationships but isolate due to severe fears of rejection, criticism, or inadequacy.
    • B. Schizotypal personality disorder: Requires cognitive or perceptual distortions, magical thinking, eccentric behavior, or ideas of reference, which are absent in this stem.
    • D. Major depressive disorder: Typically presents with a change from baseline functioning, subjective distress, depressed mood, or vegetative symptoms, whereas this patient has an enduring lifelong pattern without subjective sadness.

Board traps

  • Etiology, Defense Mechanisms, and Clinical Impact

    Do not prescribe medication as a cure for the core personality disorder itself. Psychotropics only target comorbid symptom clusters like mood dysregulation or psychosis. Additionally, do not mistake primitive defenses like splitting for primary psychotic disorders. When terminating care due to boundaries, provide a formal certified letter, referral options, and a 30 to 60 day supply of essential medications to prevent abandonment claims.

  • Clinical Mastery: Interpersonal Functioning and Impulse Control

    Prescribing psychotropic medications as a primary fix for personality disorders is a common board distractor. Medications are strictly adjunctive. When a patient with a personality disorder develops major depressive disorder, initiate standard first-line treatment with an SSRI such as sertraline, rather than second-line agents or mood stabilizers.

  • Signposts

    Confusing paranoid personality disorder with schizophrenia or delusional disorder. Paranoid personality disorder lacks fixed, persistent psychotic delusions or prominent auditory hallucinations. Do not prescribe high-dose chronic antipsychotics for non-psychotic paranoid traits.

  • Schizoid Personality Disorder

    Mistaking schizoid personality disorder for avoidant personality disorder; schizoid individuals prefer isolation and do not want social connection, whereas avoidant individuals strongly desire relationships but isolate due to intense fear of rejection.

  • Board Traps

    Avoid becoming punitive, hostile, or overly restrictive when challenged by manipulative behavior. Board exams test your ability to hold firm boundaries while maintaining a non-judgmental, professional stance.

  • Core Clinical Knowledge and Psychodynamics

    Test-writers frequently try to trick candidates into choosing psychotropic medications as the primary intervention for borderline personality disorder. Medications do not cure personality traits. Psychotropics are purely adjunctive: use SSRIs such as sertraline for comorbid mood or anxiety disorders, and reserve low-dose antipsychotics for severe agitation, transient stress-induced psychosis, or intense hostility. Never prescribe lithium or tricyclic antidepressants like amitriptyline as first-line therapy for unipolar depression in personality pathology due to toxicity risks.

  • Histrionic Personality Disorder: Attention and Emotionality

    Do not confuse histrionic attention seeking with borderline frantic efforts to avoid abandonment. Histrionic patients seek attention and vanity validation, whereas borderline patients display intense fears of rejection, severe identity disturbance, and self-destructive behaviors.

  • Narcissistic Personality Disorder: Grandiosity and Empathy Deficits

    Do not mistake narcissistic grandiosity for a manic episode of bipolar disorder. Manic grandiosity is episodic and accompanied by physiological shifts like a decreased need for sleep, whereas narcissistic grandiosity is an enduring, lifelong personality trait.

Safety alerts

  • Etiology, Defense Mechanisms, and Clinical Impact

    Assess for severe self-harm, suicidal ideation, and rapid emotional decompensation during relationship disruptions. Personality disorders significantly increase the risk of high-risk impulsive behaviors and accidental or intentional self-injury.

  • Clinical Mastery: Interpersonal Functioning and Impulse Control

    Impulsivity and interpersonal distress frequently lead to high-risk behaviors, suicide threats, or self-harm. Clinicians must monitor for splitting, where patients view people or staff as all good or all bad. Splitting arises from a failure to achieve object constancy, making it difficult for the patient to maintain emotional stability when confronted with stress or separation.

  • Signposts

    Monitor for severe agitation or paranoid escalation. Assess for comorbid substance use or mood disorders, as primitive defense mechanisms like projection can lead to acute distress.

  • Schizoid Personality Disorder

    Extreme social detachment can mask severe medical illness or profound depression because the patient rarely seeks help spontaneously.

  • Safety Alerts

    Benzodiazepines and stimulants carry a severe risk of dependence and misuse. Patients with antisocial personality disorder have a high vulnerability to co-occurring substance use disorder, making habit-forming agents unsafe.

  • Core Clinical Knowledge and Psychodynamics

    Patients with borderline personality disorder display high rates of impulsive, self-destructive, and suicidal behaviors. Benzodiazepines carry significant risks of disinhibition, worsening impulsivity, and triggering comorbid substance use disorder. If severe clinic disruption or abusive behavior necessitates ending the professional relationship, the PMHNP must avoid legal abandonment by sending a certified termination letter, providing appropriate community referral options, and supplying 30 to 60 days of emergency medication refills.

  • Histrionic and Narcissistic: Attention and Grandiosity

    Exercise extreme caution when considering benzodiazepines or psychostimulants in Cluster B populations, as these patients carry a high risk for comorbid substance use disorders.

  • Cluster B Psychopharmacology and Safety Management

    Avoid prescribing benzodiazepines or psychostimulants routinely to Cluster B patients. Personality pathology significantly increases the risk for comorbid substance use disorders, making habit-forming agents a major clinical hazard.

Compare and distinguish

No compare cards in this pack.

Memory hooks

  • B) Obsessive-compulsive personality disorder

    Cluster A is "mad" (odd/eccentric), Cluster B is "bad" (dramatic/erratic), and Cluster C is "sad" (anxious/fearful)

Car scripts